Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Katsuya Suzuki »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Katsuya Nagatani < Katsuya Suzuki < Katsuyoshi Takata  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000E01 (2015) Minoru Fujimoto [Japon] ; Satoshi Serada [Japon] ; Katsuya Suzuki [Japon] ; Ayumi Nishikawa [Japon] ; Atsushi Ogata [Japon] ; Toshihiro Nanki [Japon] ; Kunihiro Hattori [Japon] ; Hitoshi Kohsaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Tsutomu Takeuchi [Japon] ; Tetsuji Naka [Japon]Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
000F63 (2015) Ho Namkoong [Japon] ; Sadatomo Tasaka [Japon] ; Mitsuhiro Akiyama [Japon] ; Kazuma Yagi [Japon] ; Makoto Ishii [Japon] ; Katsuya Suzuki [Japon] ; Mitsutomo Kohno [Japon] ; Naoki Hasegawa [Japon] ; Tsutomu Takeuchi [Japon] ; Tomoko Betsuyaku [Japon]Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
001020 (2016) Atsuko Murota [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Takahiro Miyazaki [Japon] ; Rimpei Morita [Japon] ; Yasushi Kondo [Japon] ; Masaru Takeshita [Japon] ; Yasuo Niki [Japon] ; Akihiko Yoshimura [Japon] ; Tsutomu Takeuchi [Japon]Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
001262 (2016) Seiji Nakamura [Japon] ; Katsuya Suzuki [Japon] ; Hiroshi Iijima [Japon] ; Yuko Hata [Japon] ; Chun Ren Lim [Japon] ; Yohei Ishizawa [Japon] ; Hideto Kameda [Japon] ; Koichi Amano [Japon] ; Kenichi Matsubara [Japon] ; Ryo Matoba [Japon] ; Tsutomu Takeuchi [Japon]Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study.
001785 (2017) Shuntaro Saito [Japon] ; Katsuya Suzuki [Japon] ; Keiko Yoshimoto [Japon] ; Yuko Kaneko [Japon] ; Yoshihiro Matsumoto [Japon] ; Kunihiro Yamaoka [Japon] ; Tsutomu Takeuchi [Japon]A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis.
001956 (????) Masako Tsukamoto [Japon] ; Katsuya Suzuki [Japon] ; Noriyuki Seta [Japon] ; Tsutomi Takeuchi [Japon]Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.
001B33 (2018) Shinya Tasaki [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Masaru Takeshita [Japon] ; Atsuko Murota [Japon] ; Yasushi Kondo [Japon] ; Tatsuya Ando [Japon] ; Yusuke Nakayama [Japon] ; Yuumi Okuzono [Japon] ; Maiko Takiguchi [Japon] ; Rina Kurisu [Japon] ; Takahiro Miyazaki [Japon] ; Keiko Yoshimoto [Japon] ; Hidekata Yasuoka [Japon] ; Kunihiro Yamaoka [Japon] ; Rimpei Morita [Japon] ; Akihiko Yoshimura [Japon] ; Hiroyoshi Toyoshiba [Japon] ; Tsutomu Takeuchi [Japon]Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
002004 (2019) Masaru Takeshita [Japon] ; Katsuya Suzuki [Japon] ; Yasushi Kondo [Japon] ; Rimpei Morita [Japon] ; Yuumi Okuzono [Japon] ; Keiko Koga [Japon] ; Yoshiaki Kassai [Japon] ; Kanae Gamo [Japon] ; Maiko Takiguchi [Japon] ; Rina Kurisu [Japon] ; Hideyuki Mototani [Japon] ; Yukihiko Ebisuno [Japon] ; Akihiko Yoshimura [Japon] ; Tsutomu Takeuchi [Japon]Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell
002740 (2019) Kotaro Matsumoto [Japon] ; Katsuya Suzuki [Japon] ; Keiko Yoshimoto [Japon] ; Noriyasu Seki ; Hideto Tsujimoto ; Kenji Chiba ; Tsutomu Takeuchi [Japon]Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
002805 (2020) Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Katsuya Suzuki" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Katsuya Suzuki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Katsuya Suzuki
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021